Recent News

• 03.24.2026 - Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
• 03.24.2026 - Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
• 03.12.2026 - Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
• 03.12.2026 - Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
• 02.23.2026 - Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026
• 02.23.2026 - Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026
• 02.12.2026 - Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
• 02.12.2026 - Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
• 02.04.2026 - Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026
• 02.04.2026 - Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026

Recent Filings

• 03.17.2026 - 8-K Current report
• 02.23.2026 - 8-K Current report
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.12.2026 - EX-99.1 EX-99.1
• 02.12.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.12.2026 - 8-K Current report
• 01.27.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 01.27.2026 - 424B3 Prospectus [Rule 424(b)(3)]
• 01.26.2026 - 8-K Current report